Other Information
−Removed: Form 8-K Item 1.01 Disclosure
−Removed: On August 3, 2022, the Company entered into an amendment to the Credit Agreement with Citizens Bank, N.A.
−Removed: (the “Credit Agreement Amendment”) to, among other things, extend the maturity date of the Company’s Revolving Credit Facility to August 2, 2023.
−Removed: GLOBUS MEDICAL, INC.
−Removed: AND SUBSIDIARIES
−Removed: The foregoing description of the Credit Agreement Amendment is qualified in its entirety by reference to the text of the Credit Agreement Amendment, which is being filed herewith as Exhibit 10.1 and the terms of which are incorporated herein by reference.
−Removed: Form 8-K Item 2.03 Disclosure
−Removed: The information provided under “Form 8-K Item 1.01 Disclosure” is incorporated by reference into this Item 2.03.
+Added: Not applicable.
The following is a list of exhibits filed as part of this Quarterly Report on Form 10-Q.
2 unchanged sentences
Second Amendment to Credit Agreement, dated as of August 3, 2022, by and among Globus Medical, Inc., Globus Medical North America, Inc., and Citizens Banks, N.A.
−Removed: 2021 Equity Incentive Plan, as amended (incorporated by reference to Exhibit 10.1 to our Form 8-K filed on June 3, 2022).
+Added: (incorporated by reference to Exhibit 10.1 of the Registrant's Form 10-Q filed on August 4, 2022).
Certification by Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
GLOBUS MEDICAL, INC.
−Removed: August 4, 2022
+Added: November 8, 2022
/s/ DANIEL T.
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 4, 2022
+Added: November 8, 2022
/s/ KEITH PFEIL
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.